Advances in antibiotic and microbiome-based therapies may reduce recurrence and improve outcomes in patients with recurrent Clostridioides difficile infection.
Tori Pravato, PharmD
Advertisement
Articles by Tori Pravato, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Cyclosporiasis On the Rise in the United States, Exceeding 450 Cases
2
Study Links Several Progestogen Contraceptives to Rare Meningioma Risk, Reinforcing Individualized Patient Counseling
3
Same-Day COVID-19 and Flu Vaccination Does Not Raise Adverse Event Risk, Large VA Study Finds
4
When It Works: Best-Case Scenarios and Lessons Learned From Successful Care Transitions in Myeloma
5